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1. Introduction 
Osteoporosis is defined as a skeletal disorder characterized by loss of bone mass, decreased 
bone strength and resulting in increased risk of bone fracture. The disease is progressive 
with age, especially in postmenopausal women [1]. Osteoporotic hip fractures and vertebral 
fractures have become a major social problem because the elderly population continues to 
increase. Hip fractures account for about 10% of all osteoporosis-related fractures [2]. Hip 
fractures are particularly devastating and have a particularly negative impact on morbidity. 
Survivors often suffer severe and prolonged physical and social limitations, and fail to 
recover normal activity [3]. Vertebral fractures affect approximately 25% of postmenopausal 
women [4]. Vertebral fractures can be associated with chronic disabling pain and incur loss 
of normal activity. 
In addition to this increased awareness of osteoporosis as a significant health problem, there 
has been the emergence of several novel drugs that appear to be effective at reducing the 
risk of fracture, such as bisphosphonates. Consequently, clinicians and researchers are 
emphasizing the importance of early detection of osteoporosis, aggressive fracture 
prevention, and monitoring of patients who have high risk of fractures. Fracture risk 
associated with osteoporosis consisted of bone strength reduction and tendency to fall, 
therefore it is essential to measure bone strength to assess the risk of fracture. Bone strength 
reflects the integration of bone density and bone quality, which are influenced by bone 
architecture, bone turnover, accumulation of damage, and mineralization [5].  
Traditionally, measurement of areal bone mineral density (aBMD) by dual energy X-ray 
absorptiometry (DXA) has served as the means by which to best diagnose osteoporosis and 
evaluate fracture risk [6]. In 1994, the World Health Organization (WHO) published a set of 
diagnostic criteria to define osteoporosis in postmenopausal Caucasian women, using 
aBMD values measured by DXA [7]. Measurement of aBMD by DXA has been the standard 
method for diagnosing osteoporosis, in addition to assessing fracture risk and therapeutic 
effects. However, a variety of problems exist with DXA, which include its relatively high 
cost, the absence of DXA in many communities, especially in less-developed countries. 
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Therefore, aBMD by DXA is not a suitable screening method for fracture risk in terms of 
accessibleness and cost. In addition, the correlations between bone strength and aBMD by 
DXA are reported to be 0.51-0.80 [8-11], which indicates aBMD only accounts for 50 to 80% 
of bone strength. And the application of aBMD measurements in isolation cannot identify 
individuals who eventually experience bone fracture because of the low sensitivity of the 
test [12]. 
Recently, quantitative ultrasound (QUS) is emerging as a relatively low-cost and readily 
accessible alternative means to identify osteoporosis, evaluate fracture risk, and initiate 
osteoporosis treatment. More recently, finite element (FE) method based on data from 
computed tomography (CT) has been used to assess bone strength, fracture risk, and 
therapeutic effects on osteoporosis. 
2. Dual energy X-ray absorptiometry (DXA) 
In the 1960s, a new method of measuring aBMD, called single-photon absorptiometry (SPA), 
was developed. In this method, a single-energy photon beam is passed through bone and 
soft tissue to a detector. The amount of mineral in the path is then quantified. This method 
most commonly uses a gamma-ray source coupled with a scintillation detector, which 
together scan across the area of interest [13]. The amount of the bone mineral in the tissue 
traversed by a well collimated gamma-ray beam is derived from its attenuation through 
bone plus soft tissue relative to that through soft tissue alone. The overall thickness of the 
soft tissue is standardized, usually by immersing the limb in water or cuffing with a fluid-
filled bag. The value obtained is proportional to the bone mineral content of the segment 
scanned. The value may be divided by the bone width (yielding a result in g/cm) or by an 
estimate of the cross-sectional area to give a value for bone mineral density in g/cm2. The 
technique has been applied to the femur, humerus, metacarpal, os calcis, hand and foot, but 
the most commonly used site is the forearm. The most frequently used source is 125I (27keV), 
but has the major drawback of a relatively short half-life (60 days). 
Accuracy may be compromised by a non-uniform thickness of fat, which has attenuation 
characteristics different from those of water or lean soft tissue. In some equipment, the 
program assumes the fat to be a uniform shell around the bone and makes a correction, but 
the correction requires a number of assumptions that influence the accuracy of the method. 
The heterogeneity of surrounding tissues is nevertheless considerably less than that of tissue 
surrounding axial sites such as the spine. Although true in vivo estimates of accuracy have 
not been made, errors in cadaveric studies of excised bone have sufficiently low to make the 
technique attractive for screening [14]. 
The radiation dose of SPA is very low and applied to a small volume of tissue, giving an 
effective dose equivalent of < 1µSv. Typical scanning times are 10-15 minutes. Single-energy 
X-ray absorptiometry (SXA) is a newly developed technique suitable for scanning 
appendicular sites. It avoids the need for isotopes and is likely to replace SPA. 
The proximal femur and the vertebral bodies, with their associated processes, are very 
irregular bones that are difficult to delineate. Furthermore, they are surrounded by a widely 
varying amount of fat and muscle mass. The ratio of bone mass to soft tissue is thus lower in 
the spine or hip than in the forearm, and standardization of soft tissue by immersion in 
water is not feasible for these sites. These and other factors limit the use of SPA or SXA to 
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the appendicular skeleton. The development of dual-photon absorptiometry (DPA) and, 
more recently, dual-energy X-ray absorptiometry (DXA) have resolved at least some of these 
problems. The different thickness of soft tissue can be accommodated by simultaneous 
measurement of the transmission of gamma-rays of two different energies, which makes the 
techniques applicable to any part of the body, but particularly the lumbar spine and hip. 
The theory underlying DPA and DXA requires that there are only two components present – 
bone and soft tissue of uniform composition. In practice, fat forms a further component with 
attenuation characteristics that differ from those of water, muscle and most organs. A 
uniform layer of fat is unimportant, but fat is distributed non-uniformly in the region of the 
lumbar spine and may cause errors of up to 10% in spinal bone mineral. Errors can also be 
introduced by fat within the vertebral bone marrow. 
Total body bone mineral can be measured by DPA, but instrumental problems are greater 
because of the wide range of count rates and the non-uniform distribution of fat, which 
introduces errors. However, total body bone mineral measured by neutron activation 
analysis. As with SPA, the radiation dose for DPA is low, the effective dose equivalent for 
part-body examinations being only a few microsieverts (µSv). 
Recently, sources of gamma radiation have been replaced by X-ray generators. The necessary 
pairs of effective energies can be obtained either by K-edge filtering, using cerium or 
samarium, or by rapidly switching the generator potential. The advantages of these 
approaches are a higher beam intensity and therefore faster scan, improved spatial resolution 
with easier identification of vertebrae, and better precision. The absence of source decay also 
eliminates problems associated with decreasing count rates over the lifetime of the source. 
Like DPA, DXA determines bone mineral density from an anterior-posterior image. The 
sites most commonly measured are the lumbar spine, generally L2-L4, including the 
intervertebral discs. Other sites include the hip, forearm, whole body and skeletal segments. 
The error in reproducibility in vitro is 1-2%. DXA has been reported to have a high short-
term and long-term precision in vivo, which is about twice that of DPA. This has led to its 
widespread use in studies of osteoporosis. 
A recent development has been scanning of the lumbar spine in the lateral position, which 
has the advantage of eliminating the posterior arch and the spines of the vertebrae as well as 
aortic calcification from the measurement. Its limitations are the increased soft tissue mass 
and overlap of the projected image by the ribs and pelvis, so that only one or two vertebrae 
are measured. Lateral scanning provides a measurement of vertebral depth which, together 
with the antero-posterior area, can provide a volumetric measurement for calculating bone 
mineral mass per unit volume. Whether this volumetric density measure is a better 
predictor of fracture is unknown. The technique may be useful in assessment of bone 
density in children, allowing accurate assessment of vertebral size. The precision error of 
measurement of the vertebral body and mid-slice in vivo is of the order of 2% [15]. DXA has 
now largely replaced DPA for screening because of its greater precision, ease of use and 
freedom from several technical artifacts. The WHO defines osteoporosis as a value for 
aBMD by DXA 2.5 standard deviation (SD) or more below the mean for young Caucasian 
adult women (T-score diagnostic criteria of -2.5), based on data that this criterion identified 
30% of all postmenopausal women as having osteoporosis, more than half of whom would 
have sustained a prior fracture [7].  
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3. Quantitative computed tomography (QCT) 
In quantitative computed tomography (QCT), a thin transverse slice through the body is 
imaged. Under appropriate conditions, the image can be quantified to give a measure of 
volumetric bone mineral density (vBMD) (mg/cm3), and cancellous bone can be measured 
independently of surrounding cortical bone and aortic calcification. Developments have 
been concentrated in two directions: the construction of special equipment using a 
radionuclide source for measurements of the forearm, and the adaptation of X-ray CT 
machines installed for general radiology to measure vBMD. The attraction of the technique 
is that cancellous bone can be examined separately from cortical bone. It also gives a true 
value for mineral density (mg/cm3) unlike other techniques.  
A dedicated forearm scanner was first described in the mid 1970s [16,17]. The photon source 
is 125I and is mounted in a gantry with a sodium iodide scintillation detector. A linear scan is 
performed at each of 48 angular positions. Computer reconstruction generates an image in 
which a region of interest in the cancellous bone of the distal ulna is selected. Since 1980s, 
QCT has been used as a means for non-invasive quantitative determination of bone mineral 
of the spine [18,19]. 
A lateral plane projection scan is necessary for precise slice positioning through the centers 
of the vertebrae. Comparison between the CT Hounsfield numbers and a calibration 
standard scanned simultaneously allows bone density to be expressed in terms of the 
equivalent concentration of the material of the standard. Regions of interest within the 
vertebral bodies are selected: circular, elliptical, rectangular or other chosen areas are 
selected to include all the cancellous bone just inside the cortex. The relationship between 
the observed CT number and the true attenuation coefficient is subject to short- and long-
term variation, so that it is necessary to scan the patient and a calibration standard 
simultaneously. Recently, simple standards with fewer components based on suspensions of 
calcium hydroxyapatite in plastic have been adopted. Comparison between the standard 
and the Hounsfield numbers of the trabecular region of the vertebral bodies allows bone 
density to be expressed in terms of the equivalent concentration of the material of the 
standard.  
Investigators reported the prediction of vertebral body compressive strength using QCT. In 
1985, McBroom et al. [20] showed a strong positive correlation between QCT and apparent 
density of the vertebral trabecular bone but could find only suggestive, not quite significant, 
correlations between QCT and the vertebral body compressive strength. Cann et al. [21] 
showed that QCT evaluation of vertebral trabecular bone mineral density is a useful tool for 
determining the patients with increased risk of vertebral fracture. The positive correlations 
between QCT and vertebral body compressive strength in cadaver studies are 0.72-0.74 
[22,23]. 
The biggest source of error in X-ray CT systems is fat within the bone marrow: accuracy 
errors of up to 30%. The accuracy can be improved by carrying out scans at two different 
potentials (dual energy techniques); typically, 80 and 120 kVp are used. Kalender et al. [24] 
claim an accuracy error of 5% in vitro, but errors in vivo are likely to be larger. The effective 
radiation doses equivalent for QCT are 0.3 mSv for single energy techniques and 1 mSv for 
dual energy techniques, respectively [25]. 
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4. Quantitative ultrasound (QUS) bone assessment method  
QUS bone assessment method has been recently introduced as an alternative for peripheral 
bone mass assessment, reflecting bone strength, bone density, and bone elasticity or 
fragility, and may be superior to aBMD by DXA [26]. The advantages of this method over X-
ray-based techniques, which include low cost, portability, and no radiation exposure, have 
encouraged the use of this method for defining a stage of development of osteoporosis and 
evaluating bone fracture risk. 
There are several reports for assessing bone conditions in vivo using QUS method and 
apparatus. QUS devices can be classified mostly into 3 groups, related to the type of 
ultrasound transmission. Trabecular sound transmission is best for measuring the heel [27]. 
Cortical transverse transmission currently only is used in phalanx contact devices [28]. And 
cortical axial transmission presently is being investigated for use in phalanges, the radius, 
and the tibia [28]. Heel devices currently appear to have the most clinical applications, 
where QUS are being used and evaluated for the prediction of fracture risk, the diagnosis of 
osteoporosis, the initiation of osteoporosis treatment, the monitoring of osteoporosis 
treatment, and osteoporosis case finding. For these purposes, the recommended parameter 
of interest in clinical routine is a composite score, e.g., heel stiffness index or Quantitative 
Ultrasound Index (QUI) combining the results of broad-band ultrasound attenuation (BUA) 
and speed of sound (SOS), as measured in meters per second. 
At the present time, there is good evidence that QUS can discriminate those with 
osteoporotic fractures from age-matched controls without osteoporotic fracture [29,30]. The 
power of heel QUS to predict fracture observed in cross-sectional studies has been 
confirmed prospectively in some populations as defined by sex, age, and ethnic background. 
This is particularly true of heel QUS and for hip and spinal fractures. However, because of 
methodological issues, it is difficult to compare studies. Nonetheless, it is possible to make 
the following generations. Using QUS of the heel, the increase in relative risk for each 
standard deviation decrease in stiffness index (SI) is approximately 2.0 for the hip and spine 
and roughly 1.5 for all fractures combined [31-41]. 
The evidence from studies is good that the heel QUS SI using QUS devices is predictive of 
hip fracture risk in Caucasian and Asian women over age 55 and of any fracture risk in 
Asian women over age 55. Cortical axial transmission devices have no prospectively proven 
clinical utility, although clinical use in adults of phalanx QUS devices using cortical 
transverse transmission is also limited. These results for heel QUS are roughly the same as 
for DXA by BMD in terms of hip and spine fracture risk per SD decrease [12,42]. Discordant 
results between heel QUS and DXA, which are not infrequent, are not necessarily an 
indication of methodological error but rather due to the independence between the 2 
techniques. 
Diagnosing osteoporosis using QUS is less supported by evidence and more complicated 
and problematic than assessing fracture risk. To start with, the T-score diagnostic criteria of -
2.5, classically used for DXA aBMD, cannot be applied to QUS without discrepancies in the 
numbers of women diagnosed with osteoporosis because of tremendous variations in QUS 
measurements by skeletal site, because different QUS devices yield different results, and 
because of the relatively poor correlation between heel QUS and hip/spine DXA 
measurements. If the prevalence of osteoporosis is defined as -2.5 SD from the mean 
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threshold for QUS, even within the same sample population, different QUS instruments and 
different skeletal sites generate prevalence estimates that vary as much as 10-fold, such as 
prevalence estimates among Caucasian women over age 65 ranging from 4 to 50% [43-46]. 
To overcome this dilemma, there is a need for predefined, device-specific diagnostic 
thresholds. One recommended system suggests calibrating QUS measurements with DXA 
results, the latter used as the “gold standard,” so that an upper QUS threshold is set to 
identify osteoporosis with 90% sensitivity and a lower threshold is set to identify 
osteoporosis with 90% specificity [47]. Using such a system, one could identify osteoporosis 
with high probability in patients whose results fall below the lower threshold for QUS, 
where specificity exceeds 90%; between the upper and lower thresholds, the diagnosis of 
osteoporosis would be considered quite equivocal, so that another means of measurement, 
like DXA aBMD, would be highly recommended; and above the upper threshold for QUS, 
where the sensitivity of a value below the threshold is 90%, osteoporosis would be deemed 
unlikely. 
Except in the case of a low-energy fractures of the hip or spine, when the fracture alone is 
adequate to require treatment, all currently published recommendations for the initiation of 
treatment for osteoporosis are based on DXA aBMD values; in no instance, to date, are the 
results of QUS the definitive parameter. Despite this, several studies have demonstrated 
high levels of correlation between heel trabecular sound transmission and aBMD at matched 
skeletal sites [48-50]. Moreover, both SOS and BUA, standard QUS measurements, are 
dependent on overall bone strength which, in turn, is related to bone density, architecture 
and turnover, and the extent of bone mineralization [48,50,51-56]. These factors likely work 
together to maintain the overall quality and strength of bone and to prevent fractures and 
other bone failure. QUS parameters of heel trabecular transverse transmission are highly 
correlated with bone strength [57-62]. Consequently, it is conceivable that QUS guidelines 
for treatment initiation could be created, especially if combined with the use of clinical risk 
factors [63]. But no randomized clinical trials have been published examining whether 
individuals identified as high risk for fracture by QUS respond to treatment. 
5. Finite element (FE) method based on data from computed tomography 
The finite element (FE) method, an advanced computer technique of structural stress 
analysis developed in engineering mechanics, was first introduced to orthopaedic 
biomechanics in 1972 to evaluate stressed in human bones [64]. Since then, this method has 
been used to study the mechanics of human bones [65]. In the early 1990s, the FE method of 
analyzing a bone for fracture risk using 3-dimensional CT data was developed.  
The object of this method is to measure non-invasively the strength of an individual bone in 
an individual patient. This measurement can then be used to determine whether or not the 
bone will fracture under specified loading conditions such as those normally seen in daily 
living. It can also be used to estimate fracture risks under abnormal loading conditions such 
as occur in falling, jumping or during athletic events or heavy training regimens. This 
method uses the distribution of physical properties of bone measured non-invasively in an 
individual and mathematical analysis of that distribution to predict the risk that a bone may 
fracture under applied loads. The use of such methods relates to the clinical disease of 
osteoporosis, or in general metabolic bone diseases. In a primary application, 3-dimensional 
CT data acquired using a conventional CT scanner are used to determine the distribution of 
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bone mineral density, this distribution is used to define bone material properties, and the FE 
method of analysis is used to determine structural properties of the whole or a part of the 
bone. This information is then used to predict risk of fracture under specified loading 
conditions. Specifically, the distribution of bone material properties determined non-
invasively is used as input to a FE analysis of structural strength, and other parameters such 
as loading conditions and boundary conditions are also included in the model as needed. 
Using mathematical methods contained in commercially-available or specially written 
computer programs, the model of a bone can be incrementally loaded until failure, and the 
yield strength determined. 
A FE method based on data from CT has been applied to predict proximal femoral fracture 
[66-70]. CT-based FE method appears more predictive of femoral strength than QCT or DXA 
alone [66] and can predict proximal femoral fracture location [68]. Nonlinear FE method 
demonstrated improved predictions of femoral strength [69]. For the spine, CT-based 
nonlinear FE method was clinically applied to assess vertebral strength [71] and cadaver 
studies have been performed to evaluate the accuracy of CT-based FE method [72-77]. The 
cadaver studies have verified CT-based FE method predicts failure loads and fracture 
patterns for 10-mm-thick vertebral sections [72] and can predict ex vivo vertebral 
compressive strength better than aBMD [73,74] and QCT alone [75]. CT-based nonlinear FE 
method can accurately predict vertebral strength, fracture sites and distribution of minimum 
principal strain ex vivo [77]. Based on verification by the cadaver studies, FE method has 
been applied clinically to the assessment of chronic glucocorticoid treatment at the hip [78], 
as well as teriparatide and alendronate treatment for osteoporosis at the lumbar spine [79], 
proving useful for assessing medication effects on bone strength. 
A study assessing vertebral fracture risk and medication effects on osteoporosis in vivo with 
CT-based nonlinear FE method showed that analyzed vertebral compressive strength had 
stronger discriminatory power for vertebral fracture than aBMD and vBMD, and detected 
alendronate effects at 3 months earlier than aBMD and vBMD [80]. The CV (coefficient of 
variation) for the measurement of vertebral compressive strength was 0.96% ex vivo. The 
effective radiation dose for assessing vertebral compressive strength is 3 mSv.  
CT-based FE method predicts compressive bone strength accurately and is useful for 
assessing the risk of fracture and therapeutic effects on osteoporosis, and provides unique 
theories from a biomechanical perspective. This method also predicts bone strength under 
specified loading conditions such as those normally seen in activities of daily living [81,82].  
6. Assessment of vertebral strength ex vivo by DXA 
This study was conducted at Tokyo University in Tokyo, Japan. The study protocol was 
approved by the ethics committee. 
Twelve thoracolumbar (T11, T12, and L1) vertebrae with no skeletal pathologies were 
collected within 24 hours of death from 4 males (31, 55, 67, and 83 years old). Causes of 
death for the four donors were myelodysplastic syndrome, pneumonia, adult T-cell 
leukemia, and bladder cancer, respectively. All of the specimens were obtained at Tokyo 
University Hospital with the approval of the ethics committee and with informed consent. 
They were stored at –70 C after each step in the protocol. The vertebrae were disarticulated, 
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and the discs were excised. Then the posterior elements of each vertebra were removed by 
cutting through the pedicles. The vertebrae were immersed in water and aBMD (g/cm2) of 
the vertebrae were measured by DXA (DPX; Lunar, Madison, WI, USA) in the supine 
position. 
To assess vertebral strength, a quasi-static uniaxial compression test of each vertebra was 
conducted. To restrain the specimens for load testing, both upper and lower surfaces of the 
vertebrae were embedded in dental resin (Ostron; GC Dental Products Co., Aichi, Japan) so 
that the two surfaces were exactly parallel. Then the embedded specimens were placed on a 
mechanical testing machine (TENSILON UTM-2.5T; Orientec, Tokyo, Japan) and were 
compressed at a cross-head displacement rate of 0.5 mm per minute. A compression plate 
with a ball joint was used to apply a uniform load onto the upper surface of the specimen. 
The applied load was measured by a load cell (T-CLB-5-F-SR; T. S. Engineering, Kanagawa, 
Japan). The load was recorded using MacLab/4うAD Instruments, Castle Hill, NSW, 
Australiaえat a sampling rate of 2 Hz. The measured vertebral strength was defined as the 
ultimate load achieved. Pearson's correlation analysis was used to evaluate correlations 
between the measured aBMD by DXA and the measured vertebral strength by mechanical 
testing. 
The result from the ex vivo assessment, aBMD by DXA ranged from 0.287 to 0.705 g/cm2, 
while the measured vertebral strength by mechanical testing ranged from 1.54 to 4.62 kN. 
There were significant linear correlations between aBMD and the measured vertebral 
strength (r = 0.915, p < 0.0001) (Fig. 1). 
 
 
Fig. 1. The experimentally measured vertebral strength versus aBMD measured by DXA. 
They were significantly correlated. 
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7. Assessment of vertebral fracture risk in vivo by DXA 
This study was conducted at Tokyo Metropolitan Geriatric Medical Center in Tokyo, Japan. 
The study protocol was approved by the ethics committee and each participant provided 
written informed consent in accordance with the Declaration of Helsinki. 
The inclusion criteria included ambulatory postmenopausal Japanese women aged between 
49 and 85 years old. Exclusion criteria included women with any disorders of bone and 
mineral metabolism other than postmenopausal osteoporosis, those who had any recent or 
current treatment with the potential to alter bone turnover or bone metabolism. Vertebral 
fracture was diagnosed based on lateral spine radiography. Radiographic vertebral fracture 
was defined if either the anterior or central height was 20% less than posterior height. A 
total of 123 eligible participants were enrolled in this cross-sectional study. For all 
participants, aBMD of the anteroposterior (AP) lumbar spine (L2-4) were measured by DXA 
(DPX; Lunar, Madison, WI, USA). 
Logistic regression analysis was performed to estimate risk factors for vertebral fracture. L2-
4 aBMD was assessed using sensitivity and specificity curves to determine the optimal cut-
off point as the vertebral fracture threshold. For each statistical analysis, differences were 
considered significant at p<0.05. Statistical analysis was performed using StatView for 
Windows version 5.0 software (SAS Institute, Cary, NC, USA). 
The 123 women enrolled in the in vivo clinical study had a mean age of 71.8 ±7.4 years, mean 
height of 149.4 ±5.6 cm, and mean weight of 50.2 ±7.4 kg. Measured L2-4 aBMD was 0.816 
±0.191 g/cm2. Subjects were classified on the basis of prior vertebral fracture. Among the 
123 women, 75 subjects did not have any vertebral fractures (nonfracture group) and 48 
subjects already had vertebral fractures (fracture group). The average aBMD of the non-
fracture group was 0.860 ± 0.166 g/cm2, which was greater than that of the fracture group at 
0.759 ± 0.207 g/cm2 (Mann-Whitney U test, p = 0.0255).  
Vertebral fractures were present in 39.0% of the total study population. Among the fracture 
group, vertebral fractures spontaneously developed in 29 women (spontaneous fracture 
group) and were caused by trauma in 19 women (traumatic fracture group). Among the 19 
subjects in the traumatic fracture group, 18 women developed fracture following a fall from 
standing height, and 1 woman developed fracture following a fall down stairs. To exclude 
factors of trauma, 75 subjects in the nonfracture group and 29 subjects in the spontaneous 
fracture group were compared. aBMD (Mann-Whitney U test, p=0.0033) was significantly 
decreased in the spontaneous fracture group compared with the nonfracture group. Logistic 
regression analysis after adjustment for age and body weight revealed that aBMD reduction as 
risk factors associated with spontaneous vertebral fracture, the odds ratio per SD decrease was 
1.83 with 1.13-3.26 of 95% confidence interval (p=0.0238). aBMD was also assessed by 
sensitivity and specificity curves. The nonfracture group and spontaneous fracture group (104 
women in total) were assessed in a cross-sectional manner. The optimal point on the sensitivity 
and specificity curves used as the fracture threshold to predict spontaneous vertebral fractures 
for aBMD was 0.816 g/cm2 with 69.0% sensitivity and 72.0% specificity (Fig. 2). 
8. Discussion 
Bone strength primarily reflects bone density and bone quality, which are influenced by 
bone architecture, turnover, accumulation of damage, and mineralization [5]. Previous  
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Fig. 2. Sensitivity and specificity curves to determine the optimal cut-off point of aBMD 
measured by DXA to predict spontaneous vertebral fracture. 
studies showed that aBMD explained 50-80% of vertebral strength [8-11] based on data that 
the correlations between aBMD and the measured vertebral strength were 0.51 to 0.80. In 
this study, the correlations between the measured values of aBMD and the vertebral 
strength were 0.915 and better than the previous studies. This ex vivo study showed that 
aBMD measurements in isolation might assess vertebral strength well. 
In the treatment of osteoporosis, the target is to assess fracture risk and prevent fractures. 
This in vivo study showed that aBMD had high discriminatory power for spontaneous 
vertebral fracture. The cut-off value of aBMD for predicting vertebral fractures without 
trauma was 0.816 g/cm2, equivalent to -2.62 SD compared to young healthy Japanese women. 
Low trauma fractures such as a fall from a standing height are due to osteoporosis. The 
present assessment excluded the traumatic fracture group. Therefore, the threshold value was 
not for diagnosing osteoporosis, but for assessing spontaneous vertebral fracture risk. 
This ex vivo and in vivo study showed that aBMD was a good parameter of vertebral strength 
and vertebral fracture risk. However, aBMD in isolation can only assess bone density and 
can not assess bone quality. Therefore, accuracy of assessing vertebral strength by aBMD is 
limited. 
To improve accuracy of assessing vertebral strength and vertebral fracture risk, new method 
has been developed. CT-based nonlinear FE method can accurately predict vertebral 
strength, fracture sites and distribution of minimum principal strain ex vivo [77]. Based on 
verification by the cadaver studies, FE method has been applied clinically. A study assessing 
vertebral fracture risk and medication effects on osteoporosis in vivo with CT-based 
nonlinear FE method showed that analyzed vertebral compressive strength had stronger 
discriminatory power for vertebral fracture than aBMD and detected alendronate effects at 3 
months earlier than aBMD [80]. 
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This method assesses bone geometry and heterogeneous bone mass distribution as well as 
aBMD, but cannot detect microdamage and bone turnover. In clinical application, other 
parameters such as age and bone turnover markers should be included to assess the risk of 
fracture and therapeutic effects. Methods for assessing fracture risk and therapeutic effects 
on osteoporosis in the future might include other parameters as well as CT data. 
Prediction by FE method with a smaller element size using the data from CT scans with a 
thinner slice thickness and a smaller pixel size is more accurate. On the other hand, thinner 
CT slices lead to more radiation exposure in the clinical situation. To decrease radiation 
exposure as much as possible during CT scanning, optimization of the element size of the FE 
method was performed by assessing the accuracy of the FE method simulation [83]. With 
the limited resolution of currently available CT scanners, the micro-architecture of the bone 
cannot be precisely assessed. Micro-CT and synchrotron micro-CT visualize bone 
microstructure. However, obtaining micro-CT scans of a whole vertebra in vivo would be 
impossible with the currently available scanners. Also, use of thinner CT slices to obtain 
images leads to more radiation exposure. With future developments, FE method based on 
micro-CT data with less radiation dose might be promising. 
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